Global Pediatric Supplements Market Anticipated to Reach USD 105,374.0 Million by 2032

According to a recent market study published by Growth Market Reports, titled, “global pediatric supplements market is segmented into by product type, by form, by age group, by application, By distribution channel, and by region: Size, Share, Trends and Opportunity Analysis, 2017-2032”, the market was valued at USD 54,893.6 million in 2023 and is expected to grow at a growth rate of 7.8% by the year 2032.

Pediatric supplements are nutritional products designed to meet the dietary needs of children and adolescents, often in various forms like tablets, liquids, gummies, or powders. They fill nutritional gaps in a person's diet, especially when dietary intake is insufficient or specific deficiencies are identified. These supplements support a child's overall health and development by providing essential nutrients like calcium, iron, vitamin D, and omega-3 fatty acids. Pediatric supplements are also crucial for children recovering from illnesses, surgeries, or prolonged malnutrition.

The global pediatric supplements market has been segmented in terms of product type, form, age group, application, and distribution channel. In terms of product type the global pediatric supplements market is segmented into vitamins, minerals, probiotics, omega-3 fatty acids, amino acids and others. On the basis of form, the market is divided into gummies, chewables, liquids, powders, tablets. and others. Based on feature, the market is classified as smoke evacuation technology and without smoke evacuation technology. Based on age group is segmented into infants, toddlers, middle childhood, and adolescents. On the basis by application, market is divided into immunity enhancement, brain & cognitive support, bone & teeth support, gastrointestinal support, general well-being, and others. In terms of distribution channel, the global pediatric supplements market is divided into pharmacies, supermarkets/hypermarkets, online retailers, specialty stores, and others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Get Sample Report @ https://growthmarketreports.com/request-sample/7194

The outbreak of COVID-19 pandemic disrupted the global supply chain, due to lockdown measures, travel restrictions, and manufacturing disruptions. The COVID-19 pandemic has accelerated the global pediatric supplements market by increasing awareness of immunity and health, leading to a surge in the consumption of vitamins, minerals, and immune-boosting supplements. However, disruptions in supply chains, manufacturing, and distribution, especially during lockdowns and travel restrictions, have temporarily affected market growth.

Despite these challenges, the pandemic has fueled innovation, with companies introducing new product formats and fortifying immunity-boosting products to meet evolving consumer demands.

As per growth market reports by industry analyst Anuradha More, “Parental Awareness and Lifestyle Changes, Health Trends and Preventive Care, R&D and Product Innovation and Prevalence of Nutritional Deficiencies play a significant role in the growth of global pediatric supplements market.”

Key Takeaways from the Study:

• The players in the global pediatric supplements market include Abbott; Bayer AG; Church & Dwight Co., Inc.; Danone; Fresenius SE & Co. KGaA; Glanbia plc; Himalaya Wellness Company; Nestle.; Nordic Naturals; Reckitt Benckiser Group PLC; and Others.

• Based on product type, The global pediatric supplements market is divided into vitamins, minerals, probiotics, and other products. The vitamins segment is expected to grow at an 8.1% CAGR between 2024 and 2032 due to increased awareness of vitamin intake and the prevalence of vitamin deficiencies among children. The minerals segment, valued at USD 15,668.1 million in 2023, is expected to expand due to rising dietary deficiencies in children due to poor eating habits and processed foods.

• Based on form, The global pediatric supplements market is divided into gummies, chewables, liquids, powders, and tablets. Gummies are valued at USD 20,360.1 million in 2023 and are expected to grow between 2024 and 2032. Chewables are expected to grow at a 7.9% CAGR between 2024 and 2032 due to their ease of consumption and nutritional benefits. Liquids are expected to grow between 2024 and 2032 due to their versatility and ease of mixing with food or beverages.

• Based on age group, The global pediatric supplements market is divided into infants, toddlers, middle childhood, and adolescents. The infants segment, is expected to grow at an 8.1% CAGR between 2024 and 2032 due to increased awareness of essential nutrients and breastfeeding trends. The toddlers segment, valued at USD 14,432.4 million, is expected to grow due to increased parental emphasis on nutrition during toddlers' critical growth years. The middle childhood segment, is expected to grow due to increased physical activity and academic pressures.

• Based on distribution channel, The global pediatric supplements market is divided into pharmacies, supermarkets/hypermarkets, online retailers, and specialty stores. Pharmacies are valued at USD 19,562.1 million in 2023 and are expected to grow between 2024 and 2032. Supermarkets/hypermarkets are expected to expand at a CAGR of 7.7% between 2024 and 2032.

Market Key Developments

The players in the global pediatric supplements market include Abbott; Bayer AG; Church & Dwight Co., Inc.; Danone; Fresenius SE & Co. KGaA; Glanbia plc; Himalaya Wellness Company; Nestle.; Nordic Naturals; Reckitt Benckiser Group PLC; and Others.

On January 25, 2024, Abbott announced that it received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC DBS system, the smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system also requires the fewest recharges of any FDA-approved DBS system, needing only 10 recharge sessions a year for most people.

Report Scope

Target Audience:

• Supply-side: Manufacturer, Distributors, and Suppliers.

• Demand Side: Hospital, Clinics, End-user (Infants, Toddlers, Middle Childhood, Adolescents), and Others).

• Regulatory Side: Concerned government authorities, and other approved regulatory bodies.

• Associations and Industry Bodies: World Health Organization (WHO), Food Drug Administration (FDA), Medical Devices Regulatory Authority, Centers for Disease Control and Prevention (CDC), etc.